Quick Takeaways
- ADAR1 Capital Management, LLC filed SCHEDULE 13G/A for Grace Therapeutics, Inc. Common Stock, par value $0.0001 per share (GRCE).
- Disclosed ownership: 9.9%.
- Date of event: 31 Dec 2025.
ADAR1 Capital Management, LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Grace Therapeutics, Inc. Common Stock, par value $0.0001 per share (GRCE)
- Filing Manager
- ADAR1 Capital Management, LLC
- Reporting Manager
- ADAR1 Capital Management GP, LLC
- Symbol
- GRCE
- Shares outstanding
- 16,654,455 shares
- Disclosed Ownership
- 1,648,791 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 18:17:57 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ADAR1 Capital Management, LLC disclosed 9.9% ownership in Grace Therapeutics, Inc. Common Stock, par value $0.0001 per share (GRCE) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Feb 2026, 18:17.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 9.9% | 1,646,173 | 0 | 1,646,173 | /s/ Daniel Schneeberger | Daniel Schneeberger, Manager | |
| ADAR1 Capital Management GP, LLC | 9.9% | 1,648,791 | 0 | 1,648,791 | /s/ Daniel Schneeberger | Daniel Schneeberger, Manager | |
| Daniel Schneeberger | 9.9% | 1,646,173 | 0 | 1,646,173 | /s/ Daniel Schneeberger | Daniel Schneeberger, in his individual capacity |